ConductScience.org, home

Paper18161908

Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases (Br J Surg 2007; 94: 1133-1138).

Lordan JT and 1 other. Br J Surg, 2008. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases (Br J Surg 2007; 94: 1133-1138). Papers, record 18161908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18161908

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases (Br J Surg 2007; 94: 1133-1138).
PubMed
Journal
Br J Surg
PubMed
Year
2008
PubMed
Publication types
Comment, Letter
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.09
iCite
Revised in PubMed
2008-01-08
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lordan JTJ T
2Karanjia NDN D

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Colorectal NeoplasmsMajor topic
Liver NeoplasmsMajor topic
Carcinoembryonic Antigen
Clinical Trials, Phase III as Topic
Disease-Free Survival
Humans

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on17514637Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases.https://conductscience.org/library/papers/17514637

Source PubMed

Download CSV of comments and corrections

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
34031728Recurrence patterns and their effects on clinical outcomes after R1 resection of colorectal liver metastases: a propensity score-matched analysis.Langenbecks Arch Surg2021https://conductscience.org/library/papers/34031728PubMed
33858364Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases.BMC Cancer2021https://conductscience.org/library/papers/33858364PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18161908

GET https://conductscience.org/api/papers/v1/18161908/authors